Variant report
Variant | nsv522343 |
---|---|
Chromosome Location | chr3:88341366-88351968 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:88348034..88350434-chr3:88355298..88358101,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10446360 | chr3:88341366-88341367 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs146318633 | chr3:88341453-88341454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535808181 | chr3:88341460-88341461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77006869 | chr3:88341468-88341469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572329446 | chr3:88341474-88341475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148533583 | chr3:88341479-88341480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557441136 | chr3:88341488-88341489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34429427 | chr3:88341501-88341502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184344249 | chr3:88341539-88341540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188381468 | chr3:88341548-88341549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543566035 | chr3:88341550-88341551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372055454 | chr3:88341556-88341557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567766220 | chr3:88341607-88341608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573544970 | chr3:88341667-88341668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75783440 | chr3:88341671-88341672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76542219 | chr3:88341677-88341678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142892670 | chr3:88341713-88341714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545267447 | chr3:88341748-88341749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563498340 | chr3:88341787-88341788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181322277 | chr3:88341817-88341818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377146018 | chr3:88341835-88341836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116684626 | chr3:88341838-88341839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568378867 | chr3:88341839-88341840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529223511 | chr3:88341871-88341872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150558638 | chr3:88341881-88341882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565991987 | chr3:88341913-88341914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539740683 | chr3:88341927-88341928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139585420 | chr3:88341930-88341931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144489919 | chr3:88341940-88341941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536762328 | chr3:88341974-88341975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577511612 | chr3:88347014-88347015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538506523 | chr3:88347044-88347045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190876059 | chr3:88347180-88347181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145107681 | chr3:88347193-88347194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2219412 | chr3:88347211-88347212 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543285453 | chr3:88347300-88347301 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2199014 | chr3:88347310-88347311 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs183377099 | chr3:88347316-88347317 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2199015 | chr3:88347361-88347362 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs543813814 | chr3:88347372-88347373 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564105827 | chr3:88347454-88347455 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562197124 | chr3:88347465-88347466 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187308841 | chr3:88347490-88347491 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146859956 | chr3:88347500-88347501 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561881596 | chr3:88347501-88347502 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191933131 | chr3:88347522-88347523 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2199016 | chr3:88347562-88347563 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs560277587 | chr3:88347584-88347585 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567011645 | chr3:88347628-88347629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527781759 | chr3:88347629-88347630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:88339800-88342000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr3:88341200-88342000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr3:88347000-88347200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
4 | chr3:88347200-88347600 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
5 | chr3:88347200-88348000 | Enhancers | Primary T cells from cord blood | blood |
6 | chr3:88347400-88347800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr3:88347600-88347800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
8 | chr3:88347800-88348000 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
9 | chr3:88347800-88350000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr3:88348000-88348600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
11 | chr3:88348600-88350000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
12 | chr3:88350000-88351000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
13 | chr3:88350000-88352000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr3:88351000-88358600 | Weak transcription | Right Atrium | heart |